{
  "id": "4c33a5e11396200b",
  "title": "Inhibrx Biosciences Provides Progress Updates on the INBRX - 106 Program and the Expansion Cohorts of the ozekibart ( INBRX - 109 ) Program",
  "description": "20251216T231500Z",
  "content": "",
  "source": "prnewswire.com",
  "source_url": "https://www.prnewswire.com/news-releases/inhibrx-biosciences-provides-progress-updates-on-the-inbrx-106-program-and-the-expansion-cohorts-of-the-ozekibart-inbrx-109-program-302644003.html",
  "published_at": "20251216T231500Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.prnewswire.com/news-releases/inhibrx-biosciences-provides-progress-updates-on-the-inbrx-106-program-and-the-expansion-cohorts-of-the-ozekibart-inbrx-109-program-302644003.html",
    "url_mobile": "",
    "title": "Inhibrx Biosciences Provides Progress Updates on the INBRX - 106 Program and the Expansion Cohorts of the ozekibart ( INBRX - 109 ) Program",
    "seendate": "20251216T231500Z",
    "socialimage": "",
    "domain": "prnewswire.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}